Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer

ConclusionsLCR may be the most useful predictive factor for OS and DFS in patients with stage II or III colon cancer.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research